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•	 Magnetic nanoparticles are the most attractive nanostructures in biomedical and bio-analytical fields.
•	 The protein coating on MNPs has been found to have wide clinical and analytical applications.
•	 Coagulation factor VIII (FVIII) is a valuable therapeutic human protein in the market. 
•	 Attachment of a large protein like F VIII to GMNPs is affected by various environmental factors.
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ABSTRACT
Protein-coated nanoparticles have diverse applications in biomedical science. The protein 
hydrophobic domains or surface electrostatic charge conducts adsorption of proteins to 
different surfaces. This property can be customized to immobilize specific molecules 
on solid supports for experimental screenings or purification processes. To develop 
highly selective affinity ligands—such as aptamers—against specific protein targets, 
protein-coated magnetic particles have been successfully applied. This approach could 
be highly efficient in affinity ligand development against coagulation factor VIII.In this 
study, magnetic nanoparticles were prepared by co-precipitation method and, then, a 
gold coating was run on the MNPs’ surface. The gold coating could add some attractive 
specifications to the protein immobilized nanoparticles during the aptamer selection 
process, such as simultaneous affinity determination of aptameric oligonucleotides by 
fluorescence-based methods. The gold surface has been indicated as a specific feature 
for covalent binding to the sulphur functional groups of various molecules. In proteins, 
sulphur units of cysteine or methionine might be bound covalently to the gold surface. In 
addition, nonspecific and non-covalent attachment of proteins to the gold particles may 
be performed. Therefore, a series of samples containing different mass ratios of protein 
to gold magnetic nanoparticles (GMNPs) were evaluated to find the best conditions for 
coagulation factor VIII immobilization. The results showed that the best condition for 
high coating efficiency was 48 h incubation at 4 ºC of protein and GMNPs with a mass 
ratio of 0.5% in PBS 25mM, with pH=7 as binding buffer.
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Introduction 
Nano-materials are promising structures in various 
fields of the biological sciences. Nanostructures with 
different identities for different applications have been 
developed, using a wide variety of starting materials 
(metals and biological and chemical polymers). Among 
these, magnetic nanoparticles (MNPs), especially Fe3O4 
nanoparticles, are the most attractive nanostructures in 
the biomedical and bio-analytical fields because of their 
specific characteristics, such as superparamagneticity, 
biocompatibility, non-toxicity, and ease of synthesis (Wu 
et al., 2015; Zeinali, 2015).
Nowadays, magnetic nanoparticles are being 
extensively studied for their biomedical applications, 
such as magnetic separation, cell labelling, cellular 
therapy, drug delivery, hyperthermia treatment, and 
magnetic resonance imaging (MRI) (Colombo et al., 
2012). MNPs are among the most valuable particles in 
the protein science researches, as they are easily handled 
with an external magnet due to their paramagnetic 
feature. In addition, it is possible to change their surface 
characteristics by adding chemicals, metals such as gold, 
silica, acrylamide and agarose, or biological moieties 
such as streptavidin, monoclonal antibodies, aptamers, 
peptide ligands and lipids. The modifications result in 
specific applications.
A modified type of magnetic nanoparticles is core-
shell magnetic nano-composites that attract significant 
attention due to their extra features in addition to magnetic 
nano-structures and, now, they are being extensively 
investigated for a wide range of applications (Chatterjee 
et al., 2014). Gold-coated MNPs (GMNPs) are one of 
the promising nanosystems in this regard. The GMNPs 
were developed by the reduction of a gold salt such as 
gold chloride on the surface of pre-formed magnetite 
nanoparticles (Wang et al., 2008). GMNPs have been 
particularly designed for biomedical applications ranging 
from magnetic bio-separation to bio-imaging and targeted 
therapy (Bao et al., 2009; Qiu et al., 2010; Tamer et al., 
2010).
Protein coating on MNPs or magnetic nano-composites 
have been widely investigated for numerous clinical and 
analytical applications (Xu et al., 2014). The physical 
and chemical features of nano-materials, particularly 
their surface characteristics, affect their interaction 
with proteins. Different proteins have been studied in 
combination with MNPs to achieve medicinal or bio-
analytical applications. For example, a study evaluated 
the adsorption of bovine serum albumin, myoglobin, 
and cytochrome C to lipid-coated gold nanoparticles, 
and found that all three proteins form adsorption layers 
consisting of an irreversibly adsorbed fraction and a 
reversibly adsorbed fraction (Kaufman et al., 2007).
Coagulation factor VIII (FVIII) is a valuable 
therapeutic human protein with a molecular weight of 
about 300 KDa that has been used in the therapeutic 
regimen of haemophilia patients (Gouw et al., 2013). 
This therapeutic protein has been supplied from two 
sources: plasma or recombinant production. Regardless 
of the source that was used as starting material, protein 
purification process has a significant impact on the quality 
of the final biopharmaceutical product. Nowadays, 
chromatography-based methods, particularly affinity 
chromatography, have a special position in laboratory-
scale and industrial protein purification (Ayyar et al., 
2012; Hage et al., 2012). In the purification process of 
coagulation proteins, affinity chromatography is a highly 
efficient method (Burnouf, 2007; Gouw et al., 2013; 
Rodrigues et al., 2015; Wang et al., 2003).
In this study, immobilization of coagulation factor 
VIII on gold-coated magnetic nanoparticles (GMNPs) 
was evaluated in order to prepare a protein-fixed solid 
support for the following analytical and investigational 
approaches. Firstly, a core/shell nanostructure of gold on 
iron magnetic nanoparticles was prepared and, then, the 
best condition for the immobilization of plasma-derived 
coagulation factor VIII on the nanoparticles was assessed.
Materials and Methods
Chemicals
The iron salts—FeCl3·6H2O and FeCl2·4H2O, and PVA 
15000—were supplied by Merck chemicals (Germany). 
Electrophoresis chemicals, tetraethyl orthosilicate 
(TEOS) and Gold (III) chloride were purchased from 
Sigma (USA). Haemoctin® 500 (Biotest, UK) was used 
as plasma coagulation factor VIII sample. Better Bradford 
Protein Assay Kit of BioBasic (Canada) was used for 
protein quantification. 
Preparation of Fe3O4 @ SiO2 @ Au core/shell 
magnetic nanoparticles 
Preparation of Fe3O4 nanoparticles
The mixture of FeCl3·6H2O (1.3 g, 4.8 mmol) in water 
(15 mL) was added to the solution of polyvinyl alcohol 
(PVA 15000) (1 g), as a surfactant, and FeCl2·4H2O (0.9 
g, 4.5 mmol) in water (15 mL), which was prepared by 
completely dissolving PVA in water followed by the 
addition of FeCl2·4H2O. The resultant solution was left 
to be stirred for 0.5 h in 80 ◦C. Then NaOH (1.0 mol/L) 
was added drop-wise, with vigorous stirring, to produce 
a black solid product when reaction media reached pH 
10. The resultant mixture was heated on a water bath for 
2 h at 60 ◦C and the black magnetite solid product was 
separated, washed with ethanol three times, and then 
dried at 80 ◦C for 10 h.
Preparation of Fe3O4@SiO2 core–shell
The core–shell Fe3O4@SiO2 nanospheres were prepared 
by a modified Stober method (Esmaeilpour et al., 2014). 
Briefly, Fe3O4 (0.50 g, 2.1 mmol) was dispersed in the 
mixture of ethanol (50 mL), deionized water (5 mL) and 
tetraethoxysilane (TEOS) (0.20 mL), followed by the 
addition of 5.0 mL of NaOH (10% w/v). This solution 
was stirred mechanically for 30 min at room temperature. 
The final product—Fe3O4@SiO2—was separated by an 
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external magnet, and washed with deionized water and 
ethanol three times, and then, dried at 80 ºC for 10 h.
Preparation of Fe3O4@SiO2@Au
A 200 mg sample of the Fe3O4@SiO2 was added in 20 
mL water with 100 µL of AuCl3 (200 mg/mL), then 3 ml 
of NaBH4 (1.0 mol/L) solution was added drop-wise with 
vigorous stirring for 2h. Finally, the product—Fe3O4@
SiO2@Au nanoparticles—was separated by an external 
magnet and washed three times with deionized water and 
ethanol. At the end, gold magnetic nanoparticles were 
dried at 80 ºC for 10 h.
Protein coating on gold magnetic nanoparticles
Haemoctin as the source of coagulation factor VIII 
contains 5 mg protein as a lyophilized powder in each vial. 
Each vial was reconstituted by adding 5 mL of calcium 
supplemented Tris buffer (pH 7.4, Tris-HCl 40 mM, 
CaCl2 5 mM). Different mass ratios of protein to GMNPs 
were prepared and incubated in different conditions. After 
incubation time, GMNPs were separated from incubation 
mixture using an external magnet. Two steps of particle 
washing with buffer were run. The total supernatant 
from three runs of particle separation was collected and, 
then, the supernatant residual protein was measured by 
Bradford assay. Bradford assay was applied to measure 
the total protein, based on a serum albumin standard curve 
(Kruger, 2009). 
Electrophoretic study of the protein-coated gold 
magnetic nanoparticles 
Protein coating on GMNPs was evaluated by Sodium 
dodecyl sulphate–polyacrylamide gel electrophoresis 
(SDS-PAGE). Briefly, sample buffer 1X (200 µL; 50 mM 
Tris-HCl pH 6.8, 2.5 % SDS, 0.002 % Bromophenol Blue, 
5 % β-mercaptoethanol, 10 % glycerol) was added to each 
sample of protein-coated GMNPs and the contents were 
boiled for 10 min on a water bath. Then, particles were 
separated by external magnet and supernatant sample (40 
µL) was applied to the SDS-PAGE (4 % stacking gel–10 
% resolving gel). 
Instrumentation 
Magnetometery 
Magnetic properties were evaluated by vibrating sample 
magnetometer-BHV-55 model (Riken Denshi Co., China).
Fourier transform infrared (FT-IR) spectroscopy
Fourier transform infrared (FT-IR) spectra were recorded 
(Perkin Elmer spectrometer, USA) at room temperature.
UV–visible spectroscopy 
UV–visible (UV–vis) absorption spectroscopic 
measurements were recorded using ScanDrop 
(Analyticjena, Germany).
Particle size analysis 
Particle size analysis was performed by Dynamic Light 
Scattering (DLS) method using ZetaSizer Nano ZS-
ZEN3600 model (Malvern, UK). Samples were analysed 
in aqueous solution at room temperature.
Results 
Fe3O4@Au core-shell magnetic nanoparticles
Silica coating was considered to improve the stability of 
the Fe3O4 magnetic nanoparticles prepared. Then, gold 
shell was added to the silica-coated Fe3O4 MNPs. The 
particle size of final core/shell nanocomposites was 169 
nm (PdI=0.231) compared to 203 nm of SiO2@Fe3O4 





Figure1. FTIR spectra of SiO2 coated Fe3O4 magnetic nanoparticles.
Figure 2 
 
Figure 2. FTIR spectra of gold coated Fe3O4@SiO2.
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potential to -1.46 mv.
Coatings of silica and gold were confirmed by FTIR 
(Figure 1). The absorption peak of around 580 cm-1 
indicated the stretching vibration mode of Fe-O and Fe-
O-Si bonds, while the absorption peak of 1000–1150 cm-1 
typically referred to the stretching vibration of Si-O-Si 
and Si-OH groups. A shift to the lower wavelength for the 
absorption peak (1015 to 986 cm-1, Figure 2) confirmed 
the gold coating on SiO2 shell of MNPs. Moreover, the 
peaks 1614 cm-1 and above 3300 cm-1 were caused by the 
adsorbed water in the sample.
The magnetic properties of nanoparticles were 
measured by VSM at room temperature (Figure 2). Both 
MNPs and gold-coated MNPs showed a typical super 
paramagnetic manner. The phenomenon of hysteresis was 
not found, and the magnetization and demagnetization 
curves were coincident.
Protein coating on GMNPs
Coating of coagulation factor VIII on GMNPs were 
evaluated on the basis of three factors: included protein 
to GMNPs mass ratio, time, and buffering agent. The 
binding efficiency was calculated in accordance with 
the percentage of residual protein in supernatant, after 
magnetic separation, compared to the starting protein 
mass (Table 1). Among different protein to GMNPs mass 
ratios that were evaluated in this study, the best condition 
was achieved in 0.5% (w/w). In samples with high protein 
content, the nanoparticles were extensively aggregated. 
This might be the result of the large size of coagulation 
factor VIII, which would simultaneously attach to more 
than one nanoparticle. According to the different binding 
buffers with different pH that were studied (Tris-HCl 
40mM, pH=6-8; PBS 25mM, pH=7), the PBS buffer with 
pH=7 showed better binding between FVIII and GMNPs 
(≥52% during 16 h incubation). In addition, results 
showed that the incubation time should be extended to 16 
hours and more, in order to attain an acceptable binding 
efficiency. Accordingly, the incubation temperature was 
set at 4 ºC, due to the protein instability in long-time 
incubation at room temperature. Moreover, the least 
volume of reaction (100 µL) exhibited higher binding 
efficiency than 200–500 µL incubation volumes. Finally, 
the binding of FVIII on the GMNPs was evaluated by 
SDS-PAGE (Figure 3) that confirmed the presence of 
FVIII bound to the prepared MNPs. The best condition 
for high coating efficiency (86% binding) was achieved 
after 48 h incubation at 4 ºC of protein and GMNPs with 
mass ratio of 0.5% in PBS 25mM with pH=7 as binding 
buffer. The decrease in the binding percentage after 72 h 
incubation could be the result of protein desorption from 
the particles, which indicated some instabilities in protein 
attachment to GMNPs.
FTIR analysis of protein-coated particles revealed that 
the protein F VIII was coated on the GMNPs (Figure 5). 
Absorption peak 2984 cm-1 indicates the alkyl group-CH2, 
1629 cm-1 for C=O of amide I, 1552 cm-1 for amide II 
and 3189 cm-1 for hydroxyl groups confirmed the protein 
coating on GMNPs.
Particle size was increased after protein coating on 
GMNPs and the average size of 619 nm (PdI=0.244) 
was recorded. The zeta potential of protein-coated nano-
composites was recorded as -8.32 mv. 





PBS; pH=7 Tris-HCl; pH=6 Tris-HCl; pH=7 Tris-HCl; pH=8
0.5 15 14 12 10 2
0.5 18 16.5 13 11.5 4
0.5 26 21.6 20.5 19 8
0.5 52.4 49 36 38 16
1 12 10 9.5 8 2
1 14 14 11 10 4
1 20.6 19.3 16.5 17 8
1 38 39 26.2 19 16
2 13 12.3 11.6 10 2
2 16 14.9 12 11.3 4
2 25.3 25.1 23 20.6 8
2 46 36 29.2 21.3 16
0.5 86 69 58 32.2 48
0.5 75 65 49.3 29.8 72
Note: Temperature was set at room temperature for 2 & 4 hours incubation and 4ºC for 8 h and more incubation time
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Discussion
Magnetic nanostructures have been developed by various 
procedures, which involve physical, chemical and 
biological methods. These methods involve precipitation 
from solution, co-precipitation, high temperature 
decomposition of organic precursors, gas-phase 
deposition, electron beam lithography, sol-gel synthesis, 
oxidation method, hydrothermal reactions, aerosol/
vapour phase method and microbial incubation. Co-
precipitation method may be the most promising one due 
to its simplicity, productivity, ease of implementation and 
need for less hazardous materials (Indira and Lakshmi, 
2010; Xu et al., 2014). Naked iron-based magnetic 
nanostructures are chemically and physically unstable. 
Therefore, coating of iron MNPs with natural or synthetic 
polymers has been used and evaluated in this respect, and 
exhibited promising results (Turcheniuk et al., 2013; Xu 
et al., 2014). In this study, silica coating was applied to 
stabilize iron-based magnetic core. The coating resulted in 
a more negative zeta potential and was confirmed by FTIR. 
The results of magnetometery indicated that coating of 
Fe3O4 significantly decreased the magnetization property. 
However, the separation of the GMNPs by applying an 
external permanent magnet could make the recovery of 
the nanoparticles straightforward.
Coagulation factor VIII is one of the valuable therapeutic 
proteins that has been purified from plasma or recombinant 
source by different chromatography processes, especially 
affinity chromatography (Burnouf and Radosevich, 
2001; Rodrigues et al., 2015). Aptamers—as a selective 
affinity ligand—could be applied in protein purification 
Figure 3 
Figure 3.  Magnetization curves at 300 K for (a) Fe3O4, (b) Fe3O4@SiO2@Au.
Figure 4 
 
Figure 4. Electropherogram of FVIII coated GMNPs on 10% SDS-PAGE; from right to left: wide range protein ladder (10-250KDa), 100 µL 
reaction 2, 4, 8, 16, 48 and 72 hours incubation. The band above 250KDa is the FVIII (~300KDa) and the other band around 65 KDa is the 
contaminating coagulation factor II in Haemoctin.
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(Lim,et al.,2013; Lönne,et al.,2015; Qiao,et al.,2015; 
Wang,et al.,2015). The magnetic nanoparticles provide 
good solid support for protein specific aptamer selection 
(Yang et al.,2016). Accordingly, we tried to immobilize 
coagulation F VIII on GMNPs in a way that could be 
applied for specific aptamer selection. F VIII Protein 
attachment to the gold surface of GMNPs was performed 
by at least 16 hours’ incubation of F VIII with GMNPs 
in 4 ºC, regarding less stability of the protein at room 
temperature (Wang et al.,2003). The results confirmed 
that the amount of coagulation factor VIII coating on the 
GMNPs were significantly low in the short incubation 
time. The large size of coagulation factor VIII and the 
probability of only one sulphur group being present on the 
protein surface (according to the computational modelling 
by visual dynamic modelling ‘VMD’ software) might 
result in slow protein binding to GMNPs. Protein coating 
resulted in some particle size growth, which might be the 
result of protein-assisted aggregation of nanoparticles. 
In addition, according to the F VIII instabilities and also 
lack of stable attachment of the protein to GMNPs (as 
seen by a reduction in the binding percentage after 72 h, 
compared to 48 h incubation), it should be considered that 
the protein-coated GMNPs have to be used immediately 
once the preparation was completed.
Conclusion 
In the case of magnetic nanoparticles, simple handling, 
various surface modifications and large surface area make 
them one of the most promising analytical materials. 
Gold nanoparticles have also been extensively studied in 
biomedical and bio-analytical fields of application. Coating 
of coagulation factor VIII on magnetic nanoparticles 
can provide a valuable protein-coated solid support for 
further analytical applications. The results of this study 
showed that the direct attachment of FVIII onto the 
surface of GMNPs could be achieved, but this encouraged 
aggregation of particles. Therefore, the final product 
ended with protein-coated GMNPs in the micrometre 
range of size. In addition, the protein was non-specifically 
adsorbed on the GMNPs’ surface. Consequently, it would 
be better to add a linker within in order to conduct the 
protein binding in a defined orientation.
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